Global Bio-Risk &
Genomic Surveillance.
Investigating the intersection of genomic surveillance, dual-use technology governance, and pandemic preparedness to generate evidence that strengthens public health response and policy.
Research Focus Areas
Research translating complex multi-omics data and pathogen surveillance into evidence-based guidance for public health and policy networks.
Biorisk Management
Developing protocols to detect, contain, and respond to engineered and naturally occurring biological threats.
Genomics & Omics
Advancing research in transcriptomics, bio-markers, and the metabolic pathways of systemic disease.
Dual-Use Tech
Governance frameworks for biotechnologies that possess both therapeutic and destructive potential.
Pandemic Response
Developing rapid-response strategies for high-consequence biological events and zoonotic spillover.
Unit Leadership
Led by specialist researchers in biological risk, complex genomics, and global public health science.
Pending Appointment
Lab A Lead
Global Bio-Risk & Genomic Surveillance
Dr. Ari Meerson
Lab B Lead
Genomics & Biological Systems
Expert in molecular genomics, Oxford Nanopore sequencing, and microRNA biomarkers for chronic disease.
Regulatory Compliance Note
Unit 01 (Bio-Risk & Genomics) is an independent applied research node operated by the International Health Research Institute (IHRI) under Pillar II (Applied Research). Participation, research alignment, or data-sharing within this unit does not confer academic credit towards the MFHEA-accredited Doctor of Health Science (DHS) programme. For information regarding our formal MQF/EQF Level 8 degree qualifications, please refer to the Doctoral School.
Partner with Unit 01
We invite practitioner-scholars, research organisations, and clinical institutions to explore independent research collaboration in genomic surveillance and biological risk. Enquiries from academic and institutional partners are welcome.